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Abstract
Neutrophils serve as a first line of defense in innate immunity owing in part to their ability to rapidly migrate towards
chemotactic factors derived from invading pathogens. As a migratory function, neutrophil chemotaxis is regulated by the
Rho family of small GTPases. However, the mechanisms by which Rho GTPases orchestrate cytoskeletal dynamics in
migrating neutrophils remain ill-defined. In this study, we characterized the role of p21-activated kinase (PAK) downstream
of Rho GTPases in cytoskeletal remodeling and chemotactic processes of human neutrophils. We found that PAK activation
occurred upon stimulation of neutrophils with f-Met-Leu-Phe (fMLP), and PAK accumulated at the actin-rich leading edge of
stimulated neutrophils, suggesting a role for PAK in Rac-dependent actin remodeling. Treatment with the pharmacological
PAK inhibitor, PF3758309, abrogated the integrity of RhoA-mediated actomyosin contractility and surface adhesion.
Moreover, inhibition of PAK activity impaired neutrophil morphological polarization and directional migration under a
gradient of fMLP, and was associated with dysregulated Ca2+ signaling. These results suggest that PAK serves as an
important effector of Rho-family GTPases in neutrophil cytoskeletal reorganization, and plays a key role in driving efficient
directional migration of human neutrophils.
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Introduction
Chemotaxis, the directed migration of cells driven by a gradient
of external factors, is critical for the initial phases of innate
immunity in which neutrophils sense chemoattractant mediators
and migrate from the circulation through the endothelium to
combat invading pathogens at sites of infection [1]. During
chemotaxis, neutrophils undergo dramatic morphological changes
as lamellipodia at the leading edge extend toward chemoattractant
sources and a trailing edge forms at the neutrophil rear, termed
the uropod. These polarized structures support the efficient
migration of neutrophils at speeds of up to 30 mm/min [2].
Although many studies have described the molecular mechanisms
that underlie the steps of chemotaxis (such as directional sensing,
polarization and motility), the manner in which neutrophil
‘frontness’ vs. ‘backness’ signals are coordinated to direct
migration is still not fully understood.
Most chemoattractants, including the bacteria-derived chemo-
tactic peptide f-Met-Leu-Phe (fMLP), bind to G protein-coupled
receptors (GPCRs) expressed on the neutrophil surface. GPCR-
ligand binding activates heterotrimeric G proteins and triggers
various intracellular signaling pathways. The Rho family of
GTPases, including Rac, Cdc42 and RhoA, have been shown to
play key roles in the spatial and temporal regulation of neutrophil
cytoskeletal remodeling downstream of chemoattractant receptors
during chemotaxis [2]. In their activated forms, Rac and Cdc42
promote the extension and stabilization of an actin-rich leading
edge at the front of neutrophils to generate a motile force, while
active RhoA controls myosin II-dependent contractility and
uropod retraction. Many signaling pathways have been shown to
participate in a feedback loop that maintains the formation of a
single leading edge and uropod. In the context of cytoskeletal
rearrangement, the family of p21-activated kinases (PAKs) is a
well-characterized target of Rac and Cdc42. To date, six isoforms
of PAKs have been identified; PAK1, 2, 3 (Group I PAKs) and
PAK 4, 5, 6 (Group II PAKs). Group I and II PAKs differ in their
structural organizations and biochemical features including
activation mechanisms [3]. The binding of Rac or Cdc42 GTPases
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to the p21-binding domain (PBD) of group I PAKs induces
autophosphorylation and activation of PAK as serine/threonine
kinases, whereas the binding of Cdc42 to PBD does not serve to
activate group II PAKs [3]. In neutrophils, rapid phosphorylation
of PAK1 and PAK2 isoforms has been observed after treatment
with various agonists [4,5], and PAK1 has been found at the
leading edge and phagocytic cup [6]. In a study using mouse
neutrophils as well as non-myeloid (e.g. COS-7) and myeloid cell
lines (e.g. HL-60 and RAW274), PAK1 induced Cdc42 activation
by forming a complex with Gbc and the guanine-nucleotide
exchange factor (GEF) PIXa to promote actin polymerization and
regulate PTEN distribution for efficient directional sensing [7].
However, the characterization of PAK function in human
neutrophils has been hindered by the technical limitation that
neutrophils are not susceptible to genetic manipulation in vitro, as
they are terminally differentiated and have a short life span.
Accordingly, studies of the functional roles of PAK in human
neutrophils have been restricted to the use of gene transfection/
knockdown strategies in leukemic cell lines. While PAK1- and
PAK2-knockout mice have recently been established
[8,9,10,11,12,13,14], the neutrophil phenotype in these mice has
not yet been described.
In this study, we characterized the roles of the PAK signaling in
relation to PI3K and Rho GTPase systems during fMLP-driven
cytoskeletal reorganization in primary human neutrophils. Our
data suggest that PAK2 is activated and accumulates to the
neutrophil leading edge in response to fMLP to support Rac/
Cdc42-mediated actin dynamics in a localized manner. In
addition, PAK inhibition altered the subcellular localization of
active RhoA and induced aberrant formation of vinculin-rich
complexes. PAK kinase activity played a critical role in chemotaxis
of human neutrophils as PAK inhibition led to a loss of
directionality, increased spreading and decreased migration speed,
whereas Rac or PI3K inhibition resulted in impaired directionality
or polarization, respectively. Taken together, these results suggest
that PAKs establish a ‘frontness’ signal by negatively regulating the
surface adhesion and Rho-dependent ‘backness’ signals in human
neutrophils, thus providing a mechanism for the crosstalk between
Rho-family GTPases in neutrophil cytoskeletal dynamics and cell
migration.
Materials and Methods
Reagents
For immunohistochemistry and western blot experiments, anti-
aPAK (PAK1; sc-882), cPAK (PAK2; sc-373740), bPAK (PAK3;
sc-1871) and PAK4 (sc-28779) were purchased from Santa Cruz
(Dallas, TX, USA). Anti-PAK1/2/3 pThr423 (44–942G) was
from Invitrogen (Grand Island, NY, USA). Anti-PAK2 pSer20
(2607) and myosin light chain2 pSer19 (3675) were from Cell
Signaling (Boston, MA, USA). Anti-Rac1 (23A8) and Y27632 was
from Millipore (Billerica, MA, USA). Anti-active Rac-GTP
(26903), active RhoA-GTP (26904) and active-Cdc42-GTP
(26905) antibodies were from NewEast Biosciences (King of
Prussia, PA, USA). PF3758309 was prepared as previously
described [12,15,16]. All other reagents were from Sigma-Aldrich
(St. Louis, MO, USA) or previously named sources [16,17].
Ethics Statement
All human blood donors provided written informed consent in
accordance with a protocol approved by the Oregon Health &
Science University Institutional Review Board.
Preparation of Human Neutrophils
Human neutrophils were purified as previously described [18].
Briefly, human venous blood was drawn from healthy donors into
citrate-phosphate-dextrose and layered over an equal volume of
Polymorphprep, followed by centrifugation at 500 g for 45 min at
18uC. The lower layer containing neutrophils was collected and
washed with Hank’s balanced salt solution (HBSS) by centrifuga-
tion at 400 g for 10 min. To remove contaminating red blood
cells, the pellet was resuspended in sterile H2O for 30 sec, followed
by the immediate addition of 106PIPES buffer (250 mM PIPES,
1.1 mM NaCl, 50 mM KCl; pH 7.4). After centrifugation at
400 g for 10 min, the pellet was resuspended in PMN buffer
[HBSS containing 2 mM CaCl2, 2 mM MgCl2 and 1% w/v
bovine serum albumin (BSA)].
Western Blotting
After indicated treatments, human neutrophils were lysed in
protein extraction reagent (#78505; Thermo Scientific, Waltham,
MA, USA). Lysates were separated by SDS-PAGE and transferred
onto PVDF membranes. The membranes were blocked with 5%
BSA for 1 hr prior to incubation with primary antibodies
overnight at 4uC. Following washing with TBS-T, membranes
were incubated with the appropriate secondary antibodies.
Subsequent immunoblotting was carried out as previously
described [17,19].
Immunofluorescence and Total Internal Reflection
Fluorescence (TIRF) Microscopy
Purified human neutrophils (26106/ ml) were incubated on
fibronectin-coated surfaces at 37uC for 1 hr in the presence of
inhibitors or vehicle (DMSO), followed by stimulation with fMLP.
After fixation with 4% paraformaldehyde for 5 min, cells were
permeabilized with 80% acetone for 3 min and blocked with
blocking buffer (10% fetal bovine serum, 5 mg/ml BSA in PBS)
for 10 min. For phospho-PAK staining, cells were permeabilized
with methanol. Neutrophils were stained with anti-PAK1/2/3
pThr423 (1:100), anti-PAK2 pSer20 (1:50), anti-Rac (1:100), anti-
active Rac-GTP (1:100), anti-active RhoA-GTP (1:200), anti-
active Cdc42-GTP (1:100) anti-myosin light chain2 pSer19
(1:200), anti-vinculin (1:100), or anti-actin (1:100) in blocking
buffer overnight at 4uC. Secondary antibodies conjugated with
AlexaFluor 488 or AlexaFluor 546 (1:500) and/or TRITC-
phalloidin (1:1000) in blocking buffer were added and incubated
for 2 hr in dark. Coverslips were mounted onto glass slides and
visualized with a Zeiss Axiovert fluorescent microscope. For TIRF
microscopy, purified neutrophils were plated in 8-well chamber
slide (Nunc) and treated with vehicle or inhibitors followed by
stimulation with fMLP. Cells were fixed, permeabilized and
stained for vinculin as described above. Vinculin immunofluores-
cence in a focal section of the neutrophil within ,150 nm from
the surface of coverslip was excited with a 488 nm-laser and
detected via TIRF microscopy using a Nikon TE300 microscope
equipped with a Nikon 606 oil immersion objective (NA=1.49)
and an electron multiplied CCD camera. For data presentation,
fluorescent intensities of each image were adjusted based on signals
detected in neutrophil samples treated without primary antibody.
Image analyses were performed using Colocalization Finder of
ImageJ, or a custom program in MATLAB (The Mathworks, Inc.,
Natick, MA, USA).
Insall Migration Chamber Assays
Neutrophil chemotaxis was recorded as previously described
[18]. Briefly, purified human neutrophils were incubated at 37uC
Roles of PAK in Neutrophil Cytoskeletal Dynamics
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for 30 min on fibronectin-coated coverslips. The coverslips with
adherent cells were then inverted onto an Insall chamber. After
PMN buffer in the outer wells was aspirated, fMLP-containing
PMN buffer was added to induce chemotaxis. Images were
obtained every 10 s for 30 min at 406using differential interfer-
ence contrast (DIC) microscopy as previously described [18]. In
selected experiments, cells were pretreated with indicated inhib-
itors for 15 min at room temperature prior to the experiment.
Images were analyzed using Image J plugin MtrackJ and
quantified using the CircStat toolbox for MATLAB.
Intracellular Ca2+ Measurement
Human neutrophils (26106/ ml) were loaded with fluo-4 AM
(final 2 mM) and plated on fibronectin-surface for 30 min at 37uC.
After washing with Ca2+-free HBSS, cells were incubated for
another 30 min at 37uC in PMN buffer and inverted onto an
Insall chamber. Intracellular Ca2+ spikes in neutrophils were
monitored for 15 min at 406using a Zeiss Axiovert inverted
fluorescent microscopy and analyzed using a custom MATLAB
program.
Analysis of Data
Data are shown as means6SEM. For the quantification of
immunofluorescence images, the Jarque-Bera test was used to
evaluate normality of all parameters. One-way analysis of variance
with Bonferonni post hoc correction was used to assess statistical
significance among parameters across multiple normally distrib-
uted cell parameters. The Kruskal-Wallis test was used to assess
significance among non-normally distributed parameters. For the
migration speed analysis, statistical analysis was performed using
Student’s t test. P-values of 0.05 or less were considered significant.
Results
PAK2 Translocates to Leading Edge upon fMLP
Stimulation
The PAK isoforms described in humans (PAK1–6) display a
wide range of tissue distribution. PAK2 and PAK4 are ubiqui-
tously expressed, while PAK1, PAK3, PAK5 and PAK6 expres-
sion are specific for tissues such as brain (PAK1, PAK3, PAK5 and
PAK6) and spleen (PAK1) [20,21]. Previous studies of the PAK
pathways in neutrophils have relied on biochemical assays to
monitor PAK1 and PAK2 activation [4,5]. However, little is
known about the expression and activity of PAK isoforms in
regulating neutrophil cytoskeletal reorganization and migration.
To characterize the expression of PAK isoforms in human
neutrophils, whole human neutrophil lysates were separated by
SDS-PAGE and examined for PAK expression by Western blot
using PAK isoform-specific antibodies. As shown in Fig. 1A,
neutrophils express detectable levels of PAK1, PAK2 and PAK4.
Next, to examine PAK isoform expression and subcellular
localization, PAKs were studied by immunofluorescence micros-
copy of fixed neutrophils. PAK1, PAK2 and PAK4 were all
detected in the cytosol of unstimulated neutrophils (Fig. 1B). Upon
the stimulation with the bacteria-derived peptide fMLP, PAK2
colocalized with the actin-rich leading edge of neutrophils,
whereas PAK1 and PAK4 localization was excluded from leading
edge and primarily found in the cytosol and/or the back of
stimulated cells (Fig. 1B and 1C).
We next examined whether the translocation of PAK2 to the
leading edge is associated with kinase activation downstream of
fMLP receptor signaling. In primary human neutrophils, PAK
undergoes rapid phosphorylation at specific Ser and Thr residues
in response to a number of stimuli [4,5]. Phosphorylation of PAK1
Thr423 or PAK2 Thr402 is required for full catalytic function
[22,23], whereas phosphorylation at Ser20 of PAK2 regulates
binding to the adaptor protein Nck to control PAK membrane
localization as well as PAK kinase activity [24,25]. The PAKs are
activated upon the binding of the ,21 kD Rho GTPases Rac and
Cdc42 [24,25]. Along these lines, Rac and Cdc42 GTPases
promote lamellipodia formation and regulate lamellipodia stability
through a positive feedback loop at the actin-rich leading edge of
migrating cells [26,27], including neutrophils [2,28,29]. Our
Western blot analysis showed that PAK1 Thr423 and PAK2
Thr402 residues were phosphorylated within 3 min after neutro-
phil stimulation with fMLP (Fig. 1D). In parallel, phosphorylated
PAK Ser20 accumulated at the neutrophil leading edge and
colocalized with active, GTP-bound Rac1 (71.764.4% colocaliza-
tion; Fig. 1E) and Cdc42 (49.866.0% colocalization; Fig. 1F). In
parallel, Rac2, a Rac isoform expressed in myeloid cells, was found
to localize to the cytosol and toward the leading edge with
63.668.4% of the immunofluorescence signal of Rac2 colocalizing
with Rac1, following neutrophil stimulation with fMLP for 3 min.
Together, these results suggest that a coupled activation of Rac/
Cdc42 and PAK2 are involved in leading edge formation during
neutrophil migration.
Next, we investigated the mechanisms that regulate PAK
activation in lamellipodia dynamics of activated neutrophils. To
detect the activation of PAK, we performed immunofluorescence
microscopy experiments using primary antibodies specific for
phosphorylated PAK1/2 Thr423/402. Fluorescence microscopy
revealed Threonine-phosphorylated PAK1/2 in neutrophils upon
stimulation with fMLP, which localized to the actin-rich leading
edge (Fig. 1G). To test the role of Rac GTPase in neutrophil PAK
activation, we next analyzed the effect of Rac inhibition on PAK
activation and neutrophil morphology using the Rac1/2 inhibitor
EHT1864. In Rac-inhibited neutrophils, phosphorylated PAK1/2
Thr423/402 remained at the leading edge (Fig. 1G and 1H), while
phosphorylation at PAK2 Ser20 was undetectable (data not
shown), suggesting that Rac-independent and-dependent mecha-
nisms are required for full PAK activation and PAK function in
neutrophils.
In neutrophils, Rac activation is in part regulated by PI3Ks
which promote the localization of Rac-activating GEFs to the
neutrophil leading edge [30,31,32]. Accordingly, an impairment of
PAK2 activation has been reported downstream of RANTES-
induced chemotaxis signaling in PI3Kc-deficient mouse macro-
phages [33]. As shown in Fig. 1G and 1H, treatment of
neutrophils with the PI3K inhibitor, wortmannin, failed to block
PAK phosphorylation in response to fMLP, but led to a non-
polarized accumulation of actin and phospho-PAK. This result
suggests that like Rac, PI3K activity may also play a role in the
intracellular trafficking of active PAK, but not directly in PAK
activation.
PAK Activation and Rho GTPases Mediate Neutrophil
Backness Signals
Neutrophil morphological polarity is maintained through a
balance of ‘frontness’ and ‘backness’ signals which have been
shown to be mediated by the Rho GTPases Rac/Cdc42 GTPases
and RhoA, respectively [2]. The putative roles of the Rho
GTPases and PAK in leading edge dynamics led us to hypothesize
that PAKs may maintain neutrophil ‘frontness’ by modulating
‘backness’ during neutrophil polarization. To test this hypothesis,
we assessed the effects of PAK inhibition on RhoA GTPase
activation and localization using the pharmacological PAK
inhibitor, PF3758309 [12,15,16], which inhibited the phosphor-
ylation of PAK1/2 Thr423/402 (Fig. 2A and 2B) and PAK2
Roles of PAK in Neutrophil Cytoskeletal Dynamics
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Ser20 (data not shown) in fMLP-stimulated neutrophils. While
neutrophils developed a morphological polarity following fMLP
stimulation, characterized by a significant increase in aspect ratio
(a function of the largest cell diameter and the smallest diameter),
PF3758309-treated cells underwent polarization in the absence of
any stimulation (Fig. 2C). In vehicle-treated cells, fMLP-induced
polarization was associated with an increase in the immunofluo-
rescence of active RhoA-GTP (Fig. 2D and 2E) and a decrease in
the colocalization of RhoA-GTP with actin (Fig. 2D and 2F),
suggesting that fMLP induced active RhoA accumulation at the
uropod. In contrast, PF3758309-treated cells displayed similar
signatures of cell polarization in the absence of fMLP with a
significantly higher level of active RhoA as compared to control
cells (Fig. 2D–F). Stimulation of PAK-inhibited cells with fMLP
resulted in a comparable level of active RhoA to fMLP-stimulated
control cells (Fig. 2D–F). These results suggest that PAK
contributes to neutrophil cytoskeletal dynamics under basal
conditions by suppressing RhoA-GTP accumulation and reloca-
lization.
Active RhoA binds to and activates a number of downstream
effectors including the Rho-associated kinase ROCK [2]. The
RhoA-ROCK axis has been shown to be essential for myosin II-
mediated actomyosin contraction in various cell types [27] and for
surface detachment of migrating leukocytes [34], in which ROCK
phosphorylates myosin light chain (MLC) at Ser19 to promote the
actin-stimulated ATPase activity of myosin. In neutrophils, MLC
phosphorylation plays a key role in uropod retraction [35], and in
the maintenance of backness polarity [36]. To test whether PAK
activity has a role in actomyosin contraction, we next examined
the subcellular distribution of phospho-MLC under basal and
Figure 1. PAK2 localizes to the leading edge of activated neutrophils. Replicate samples of total neutrophil (PMN) cell lysates (50 mg per
lane) were analyzed for (A) the expression of PAK1 (68 kD), PAK2 (61 kD), PAK3 (65 kD) and PAK4 (72 kD) or (D) phosphorylation of PAK1/2 Thr432/
402 at indicated time points after the addition of fMLP (10 nM) by Western blot. Human neutrophils adherent on fibronectin surfaces were treated in
the presence or absence of fMLP (10 nM) for 3 min and stained for (B) PAK1, PAK2 or PAK4 (green) and F-actin (red), (E) phospho-PAK2 Ser20 (green)
and Rac1-GTP (red), (F) phospho-PAK2 Ser20 (green) and Cdc42-GTP (red), or (G) phospho-PAK1/2 Thr423/402 (green) and F-actin (red). In selected
experiments, neutrophils were pretreated with vehicle (0.1% DMSO), EHT1864 (Rac1/2 inhibitor, 50 mM) or wortmannin (PI3K inhibitor, 100 nM).
Results are quantified from at least 60 cells and presented as the mean percentage6SEM of (C) neutrophils displaying PAK immunofluorescence at
actin-rich leading edge, or (H) neutrophils displaying phospho-PAK1/2 immunofluorescence in the fields of view. Representative images obtained
from 3 independent experiments are shown. * P,0.05, compared to the basal level. Scale ba = 10 mm.
doi:10.1371/journal.pone.0073063.g001
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PAK-inhibited conditions. fMLP induced an increase in phospho-
MLC (Fig. 2G and 2H) at sites distant from cell centroids (Fig. 2I),
suggesting a polarized mechanism of actomyosin contraction.
Phospho-MLC immunofluorescence was abrogated in the pres-
ence of the ROCK inhibitor, Y27632 (Fig. 2G and H). Inhibition
of PAK with PF3758309 led to an accumulation of phospho-MLC
in unstimulated and stimulated cells (Fig. 2G and 2H). Interest-
ingly, the loss of MLC phosphorylation resultant from Y27632 was
partially recovered by co-treatment of PF3758309 with Y27632
(Fig. 2G and 2H). Taken together, this data suggests that PAK
regulates actomyosin contraction in migrating neutrophils via
ROCK-dependent and-independent pathways.
PAK Negatively Regulates focal Complex Assembly and
Surface Adhesion
To stabilize the lamellipodium, small adhesion structures,
known as focal complexes, are formed at the leading edge via
Rac/Cdc42 activity which link integrins to surface and cytoskeletal
Figure 2. PAK inhibition leads to an accumulation of active RhoA and phosphorylated myosin light chain. (A) Human neutrophils
adherent on fibronectin surfaces were pretreated with vehicle (0.1% DMSO) or PF3758309 (PF; PAK inhibitor, 10 mM), and stimulated with fMLP
(10 nM) for 3 min and stained for phospho-PAK1/2 Thr423/402 (green) and F-actin (red). (B) The mean percentage of cells displaying phospho-PAK1/
2 immunofluorescence at basal level (white bars) or after stimulation (black bars) was quantified from at least 50 cells per treatment. (C) Cell circularity
was analyzed using MATLAB and presented as aspect ratio of individual neutrophils at basal level (white bars) or after fMLP stimulation (black bars).
(D) Neutrophils were pretreated as indicated in (A) and stimulated with fMLP (10 nM). Cells were stained for active RhoA-GTP (green) and F-actin
(red). (E) The mean relative intensity of RhoA-GTP immunofluorescence or (F) the mean percentage of RhoA-GTP/actin colocalization of individual cell
area at basal level (white bars) or after fMLP stimulation (black bars). (G) Neutrophils were pretreated with the inhibitors indicated in (A), or with
Y27632 (ROCK inhibitor, 10 mM), or a combination of 10 mM PF3758309 and 10 mM Y27632 (PF+Y27632) and stained for phospho-myosin light chain
(p-MLC; green) and F-actin (red). (H) Relative p-MLC fluorescence intensity or (I) the distance between DIC cell centroid and p-MLC fluorescence
centroid at basal level (white bars) or after fMLP stimulation (black bars). Representative images obtained from at least 3 independent experiments
are shown. * P,0.05 compared to the basal level; # P,0.05, compared to DMSO-treated cells; ** P,0.05, compared to cells treated with Y27632
alone. Scale ba = (A) and (G) 5 mm; (D) 10 mm.
doi:10.1371/journal.pone.0073063.g002
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proteins [37]. To determine the contribution of PAK activity to
focal complex assembly in neutrophils, we examined the
localization of vinculin, a marker of focal complex assembly,
under control and pharmacologically-inhibited conditions. As seen
in Fig. 3A and B, vinculin localized to the cytosol of unstimulated
neutrophils and accumulated at the actin-rich leading edge as well
as the uropod after fMLP stimulation, indicating the presence of
vinculin-containing cell adhesions. Neutrophils treated with the
Rac1/2 inhibitor EHT1864 displayed a similar pattern of vinculin
localization as compared to control cells, whereas treatment with
the PI3K inhibitor wortmannin led to the less polarized
localization of vinculin immunofluorescence (Fig. 3A and 3B).
Interestingly, PAK-inhibited neutrophils formed vinculin-positive,
filopodia-like structures at the cell periphery in response to fMLP
(Fig. 3A). Similar vinculin clusters have been found in neutrophils
treated with TNF-a [38], which confers inhibitory signals to
neutrophil motility by promoting firm adhesion and limiting
polarization. Accordingly, we next aimed to examine whether
PAK inhibition enhanced neutrophil adhesion strength by
increasing surface contacts. Neutrophil adhesion complexes were
studied by total internal reflection fluorescence (TIRF) microsco-
py, by which immunofluorescence signals adjacent (,150 nm) to
the interface between a surface and a specimen are exclusively
detected with a high spatial resolution as an indicator of surface
contact area. As seen in Fig. 3C and 3D, TIRF microscopy for
vinculin immunofluorescence revealed that PF3758309-treatment
dramatically enhanced the level of vinculin-mediated surface
contact as compared to vehicle, both in the presence and absence
of fMLP. Together, these results demonstrate that PAK may
negatively regulate surface adhesion during neutrophil polariza-
tion.
PAK Plays a Role in Neutrophil Directional Migration and
Intracellular Calcium Release
The above described PAK-mediated regulation of actomyosin
contractility and surface adhesion led us to further examine the
role of PAK in neutrophil chemotaxis. The determining compo-
nents of efficient chemotaxis include directional sensing, morpho-
logical polarization and motility. Our data show that upon
exposure to an fMLP gradient, neutrophils first uniformly spread
and then immediately developed morphological polarity, in which
the leading edge formed distinct lamellipodia to differentiate from
the uropod (Fig. 4C and Movie S1). Within 20 min, neutrophils
migrated toward the fMLP gradient at the average speed of
7.260.5 mm/min (Fig. 4A and 4B).
To better understand the roles of PI3K, Rho GTPases and PAK
signaling pathways downstream of fMLP that regulate neutrophil
chemotaxis, we characterized the directionality, polarity and
motility of migrating neutrophils in the presence of pharmacolog-
ical inhibitors. Neutrophil directionality was partially disrupted in
the presence of the PI3K inhibitor, wortmannin (Fig. 4A).
Although migration speed was unaffected (6.260.85 mm/min;
Fig. 4B), wortmannin-treated neutrophils displayed impaired
formation of a distinct leading edge and uropod (data not shown).
The presence of the Rac1/2 inhibitor, EHT1864, led to a random
migration pattern with a migration speed comparable to vehicle-
treated cells (6.360.56 mm/min; Fig. 4A and 4B). Treatment of
neutrophils with the ROCK inhibitor, Y27632, resulted in the
formation of longer or undetached uropods (data not shown),
Figure 3. PAK inhibition enhances vinculin-mediated surface contacts. Human neutrophils adherent on fibronectin surfaces were treated in
the presence or absence of fMLP (10 nM) for 3 min. In selected experiments, neutrophils were pretreated with PF3758309 (PF; PAK inhibitor, 10 mM),
EHT1864 (Rac1/2 inhibitor, 50 mM) or wortmannin (PI3K inhibitor, 100 nM). (A) Cells were stained for vinculin (green) and F-actin (red). Arrows indicate
filopodia-like vinculin clusters shown in the insets. (B) Pearson’s coefficient for vinculin and actin immunofluorescence in cells treated as indicated in
(A). (C) Neutrophil surface vinculin was visualized using TIRF microscopy. Arbitrary units (a.u.) for vinculin signal intensity are shown. (D) The mean
TIRF signals of vinculin immunofluorescence were quantified from at least 5 cells per treatment. * P,0.05 compared to the basal vinculin signal in
DMSO-treated cells. Scale ba = (A) 10 mm; (C) 2 mm.
doi:10.1371/journal.pone.0073063.g003
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although neutrophil motility was not significantly reduced
(5.160.47 mm/min; Fig. 4A and 4B). In contrast, neutrophils
treated with PF3758309 underwent enhanced spreading in
response to fMLP (Fig. 4C and Movie S2) and randomly migrated
at a dramatically reduced migration speed (3.160.21 mm/min;
Fig. 4A, 4B and 4D) in a concentration-dependent manner
(Fig. 4E). These results suggest that PAK activity plays a crucial
role in coordinating directional sensing, polarity and motility of
chemotaxing neutrophils.
fMLP receptor signaling induces intracellular Ca2+ transients
via the activation of the Gbc complex and phospholipase C,
triggering Ca2+-dependent downstream pathways such as protein
kinase C [2,39]. These pathways have been shown to collectively
play a role in cytoskeletal dynamics in neutrophils [40]. PAK1-
deficient bone marrow-derived mast cells have been shown to
exhibit diminished intracellular calcium mobilization [9,13].
However, a role for the PAK pathway in the coupling of calcium
signaling during neutrophil chemotaxis has not been explored.
Next, to characterize the role of PAK in intracellular Ca2+
mobilization, neutrophils were loaded with the Ca2+-sensitive
reporter dye fluo-4 AM and allowed to migrate under a fMLP
gradient while intracellular Ca2+ release was measured for 15 min.
As shown in Fig. 5, neutrophils exhibited a single spike of Ca2+
release upon exposure to fMLP, followed by a gradually
decreasing level of Ca2+ during chemotaxis. In contrast, neutro-
phils treated with the PAK inhibitor, PF3758309, displayed
multiple peaks of Ca2+ release and failed to develop polarized
morphology or migrate toward the fMLP gradient (Fig. 5). These
data imply that PAK activity contributes to the regulation of
intracellular Ca2+ transients during neutrophil chemotaxis.
Discussion
The efficient migratory ability of neutrophils requires a network
of interactions between distinct cytoskeletal signaling systems,
namely frontness signals regulated by actin-dependent membrane
protrusion and backness signals mediated by myosin-dependent
cell contraction. Recent studies suggest that crosstalk processes
between frontness and backness modules during the initiation,
establishment and maintenance of neutrophil polarization are
dynamic and complex [41]. Moreover, the mediators of temporal
and spatial regulation in this crosstalk network remain to be
elucidated. In this study, we identified the p21-activated kinase
PAK as a regulator of neutrophil cytoskeletal reorganization. The
PAK family proteins serve as effectors downstream of Rac and
Cdc42 GTPases and are noted for roles in cytoskeletal dynamics,
gene transcription, survival signaling, and cell cycle progression
[25,23]. Here we find that the kinase activity of PAK is required
for the efficient directional migration of human neutrophils, where
PAK2 may serve key roles in frontness signals at the leading edge.
The absence of PAK activity resulted in an impairment of
polarization, which was associated with increased backness signals
and surface adhesions. Together, as depicted in Fig. 6, our data
describe a differential spatial regulation of PAK isoforms in fMLP-
stimulated human neutrophils and highlights a potential mecha-
nism for PAK-mediated crosstalk between Rho GTPases during
cytoskeletal reorganization.
The expression of the six PAK isoforms differs according to cell
and tissue type, implying that PAK family isoforms may have
specific and distinct functions in differing physiological contexts
[20,21]. Recent studies have reported functional differences for
PAK1 and PAK2 in various model systems. In hematopoietic stem
and progenitor cells, PAK2 plays a major role in coordinating
cytoskeletal and proliferative pathways that are essential for
engraftment of these cells [14]. PAK1 and PAK2 have been shown
to differentially modulate adhesion, RhoA activity and MLC
phosphorylation during mast cell degranulation [13] and tumor
cell migration [42]. Here, we find that human neutrophils express
PAK1, PAK2 and PAK4, and that PAK2 may play a specific role
in the regulation of actin dynamics at the leading edge upon
neutrophil activation. Whether PAK1 and PAK4 have any role in
mediating cytoskeletal regulation at non-leading edge regions of
Figure 4. PAK inhibiton blocks neutrophil chemotaxis. Human neutrophils were treated with vehicle (0.1% DMSO), EHT1864 (Rac1/2 inhibitor,
50 mM), wortmannin (PI3K inhibitor, 100 nM), Y27632 (ROCK inhibitor, 10 mM), or PF3758309 (PAK inhibitor, 10 mM) for 15 min and chemotaxis was
induced by adding fMLP (10 nM) in the outer well of an Insall chamber. Time-lapse images were obtained every 10 s for 20 min at 406magnification
using DIC microscopy. (A) The migration paths of individual cells were quantified as spider plots using MtrackJ (Image J) and MATLAB. (B) Average
migration speeds of neutrophils treated as indicated in (A). (C) Representative time-lapse images of DMSO- or PF3758309-treated cells at the first 0, 5,
10, 15 min with cell paths (white). (D) Representative kinetics of cell migration was plotted against time. (E) A dose-dependent inhibitory effect of
PF3758309 on average migration speed. Results were obtained from 3 independent experiments and data quantification was performed for at least
30 cells per treatment. * P,0.05 compared to the average migration speed of DMSO-treated cells. Scale bar = 20 mm.
doi:10.1371/journal.pone.0073063.g004
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migrating neutrophil requires further investigation. Along these
lines, PAK1, but not PAK2, has been shown to positively regulate
IgE-mediated degranulation in mast cells by regulating extracel-
lular Ca2+ influx through a mechanism involving cytoskeletal
dynamics, although the molecular details of such events remain to
be explored [9,13]. It is possible that the dysregulation of Ca2+
mobilization by PAK inhibition in our human neutrophil study
was a direct result of the blockade of the activity of specific PAK
isoforms. Further studies are required to determine whether any of
these PAK isoforms can serve as a scaffold for signaling proteins to
facilitate polarization, dependently or independently of their
kinase activity, in human neutrophils. Notably, the pharmacolog-
ical PAK inhibitor PF3758309 utilized in this study does not allow
for the selective inhibition of specific PAK isoforms, as this
compound inhibits all PAK isoforms (PAK1–6) [12]. Future
studies will be aim to define specific roles for PAK isoforms in
neutrophil function using bone-marrow specific, inducible PAK-
deficient mouse models, together with second generation PAK
inhibitors with distinct target specificities.
Antagonistic signals between Rac1/2, Cdc42 and RhoA
stabilize the polarity of migrating cells by restricting actin
polymerization to the leading edge and myosin-dependent
contraction to the uropod [2,43]. For efficient uropod retraction
during migration, the RhoA-ROCK-myosin axis plays an essential
role in myeloid cell lines, as the expression of dominant negative
RhoA [36] or the pharmacological inhibition of ROCK [36,44]
leads to multiple lamellipodial protrusions and a mislocalization of
phosphorylated MLC. In our experiments, the inhibition of PAK
in unstimulated neutrophils promoted the accumulation of active
RhoA and phospho-MLC at the cell periphery (Fig. 2), suggesting
that the basal PAK activity can suppress the development of
backness signals. The molecular mechanisms that bridge PAK
activation and RhoA regulation in neutrophils have not been
completely described. As Rho GTPases can be activated by
multiple GEFs, which promote the release of GDP and the
binding of GTP in specific cellular contexts [27], it is possible that
PAK may modulate the activity of Rho GEFs such as GEFH1 [45]
and PDZ RhoGEF [46] in a localized manner. Furthermore, our
data imply that PAK can regulate MLC phosphorylation through
RhoA/ROCK-independent pathways (Fig. 2G and 2H). Potential
alternative pathways for MLC phosphorylation include Ca2+-
dependent myosin light chain kinase (MLCK), as the phosphor-
ylation of MLCK by PAK has been shown to inhibit MLCK
activity [47].
In motile cells, adhesion strength is one of the determining
factors for migratory ability. Focal complexes, consisting of
integrins and adhesion complex proteins such as vinculin, stabilize
the lamellipodium by supporting surface attachment, and
contribute to efficient cell migration [37]. Several studies have
shown that in transfected cell lines, the binding of active Rac/
Cdc42 to PAK induces the recruitment of PAK to focal complexes
[48,49]. A study by Delorme-Walker et al. utilizing an epithelial
cell line demonstrated that PAK inhibition resulted in the
disruption of actin turnover, myosin II and focal adhesion
dynamics [50]. In rapidly migrating cells such as neutrophils,
however, the formation of focal complexes is less visible, likely as a
result of their rapid migration [37]. Our current study demon-
strated that the absence of PAK activity led to a filopodia-like
clustering of vinculin in human neutrophils (Fig. 3). These results
provide a novel regulatory mechanism for PAK-dependent surface
adhesion in migrating neutrophils.
In summary, our data describe PAK as a key coordinator of
cytoskeletal dynamics during cytoskeletal reorganization in human
Figure 5. PAK inhibition alters neutrophil calcium signaling. Human neutrophils were loaded with the intracellular Ca2+ dye fluo-4 (2 mM) and
plated on fibronectin-coated surfaces. After treatment with DMSO or PF3758309 (10 mM), neutrophil chemotaxis was induced by the addition of fMLP
in an Insall chamber. Intracellular Ca2+ release was monitored every 5 s for 15 min by fluorescent microscopy. (A) Time-lapse images after the peak
Ca2+ spike were shown. (B) Ca2+ spikes in cells treated with 0.1% DMSO (black line) or PF3758309 (PF; PAK inhibitor, dotted line) were quantified and
presented as mean intensity of at least 5 neutrophils in a field of view. Data shown is representative from 3 independent experiments. Scale
ba = 20 mm.
doi:10.1371/journal.pone.0073063.g005
Figure 6. A model for PAK-mediated cytoskeletal regulation in
human neutrophils. PAK coordinates the crosstalk between Rho
GTPases and cytoskeletal dynamics in migrating neutrophils.
doi:10.1371/journal.pone.0073063.g006
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neutrophils and demonstrates that PAK mediates the crosstalk
between the Rho GTPases to maintain the balance of front and
back polarity signals. Future studies are required to characterize
the functional roles of PAK in neutrophil inflammatory responses
such as oxidative burst, degranulation, phagocytosis and neutro-
phil extracellular trap formation.
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